Glyphosate and Cancer: IARC vs. EPA

The WHO's cancer research arm classified glyphosate (Roundup's active ingredient) as a 'probable carcinogen,' while the EPA maintains it is safe — with evidence that Monsanto influenced key regulators and research.

Dossier

Established

The IARC classified glyphosate as a 'probable carcinogen' in 2015, while the EPA maintains that it is safe when used as directed. Numerous lawsuits have been filed against Monsanto, claiming glyphosate exposure caused cancer among users.

Alleged

Critics argue that Monsanto has influenced regulatory bodies and research outcomes to favor glyphosate's safety, raising questions about the integrity of safety evaluations. There is a body of independent research suggesting a link between glyphosate exposure and various types of cancer, particularly non-Hodgkin lymphoma, which the EPA has not accepted.

Still open

The definitive relationship between glyphosate exposure and the risk of cancer remains unresolved, with ongoing research and litigation continuing to shape the debate.

Who profits

Manufacturers and stakeholders in the agricultural sector benefit from the ongoing use of glyphosate, as its use is crucial for crop management and economic profitability. Regulatory bodies may also face pressure to maintain favorable conditions for agricultural practices that rely heavily on such chemicals.

ENZØ observation

The juxtaposition of IARC's classification and the EPA's stance reveals a profound inconsistency. Regulatory bodies are pitted against one another, creating a narrative fracture. Evidence of Monsanto's influence lingers like a shadow, suggesting possible manipulation of safety assessments. Critics raise valid concerns over regulatory capture, while proponents lean heavily on industry-sponsored studies. The public is left with competing claims intertwined with financial interests. Trust in these institutions appears to ebb and flow depending on the audience. Significant gaps remain in transparency and accountability.

// anomaly.echo: When safety becomes a battleground, who emerges unscathed?

Verdict

The safety and carcinogenic potential of glyphosate remains a deeply divisive issue, with strong arguments on both sides. While mainstream regulatory agencies maintain its safety, alternative viewpoints cite significant independent research suggesting potential risks. Readers should consider exploring both perspectives and the broader implications of glyphosate use in agriculture.